Evidence map›Paper›PMID 41976572›Full record

ArticleMaterials (Basel, Switzerland)2026

Accelerated Ageing of Blast Furnace Cement-Dolomite Mortars: Phase Changes, Microstructural Evolution, and Mechanical Performance.

Elena Sutormina, Marjan Marinšek, Anton Meden

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elena SutorminaLaboratory for Demonstration of H2 and CO2 Technologies, National Institute of Chemistry, Loke Pri Zagorju 14b, 1412 Kisovec, Slovenia.ORCID 0000-0002-6524-7835
Marjan MarinšekFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0978-4388
Anton MedenFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, 1000 Ljubljana, Slovenia.

Funding

The Slovenian Research and Innovation Agency P1-0175
6 · The paper itself

Abstract

Blast furnace cement-dolomite mortars prepared from commercial cement (CEM-III/B) containing ~75% of slag and natural dolomite were aged under accelerated conditions at 60 °C in 1 M NaOH for 0-24 months. The hydration products and microstructure features of the mortars were studied using XRD, TGA and SEM-EDS methods, with blast furnace cement paste for comparison. The results showed that the presence of dolomite enhanced slag hydration, as the carbonates released during dedolomitisation promoted Ca and Si dissolution from the slag grains. After prolonged ageing, a multi-rim structure was observed around the slag particles: the inner rim primarily consisted of a hydrotalcite-like phase mixed with C-S(A)-H gel, while the outer rims were richer in C-S(A)-H gel, with varying calcium content. Monocarbonate phase was additionally detected at the slag-paste interface in the presence of dolomite. The observed increase in mechanical strength during ageing had to do with two reasons: (i) the increase in hydration product content and (ii) the densification of microstructure due to the formation of calcium carbonate, which filled pores and microcracks and the possible carbonation of C-S (A)-H gel in the binding paste. Under the investigated alkaline ageing conditions, dolomite acts as a chemically active component rather than an inert filler, influencing both slag hydration kinetics and the composition of the resulting hydration products.

Indexed as

blast furnace cement-dolomite mortarsdedolomitisationmechanical propertiesmicrostructurephase compositionslag hydration

Identifiers

PMID41976572
PMCPMC13074497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.